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Correction: Preeclampsia and risk of end
stage kidney disease: A Swedish nationwide
cohort study
Ali S. Khashan, Marie Evans, Marius Kublickas, Fergus P. McCarthy, Louise C. Kenny,
Peter Stenvinkel, Tony Fitzgerald, Karolina Kublickiene
In the Funding section, the following information was inadvertently omitted: Additional fund-
ing to KK from the Swedish Research Council grant no. 2018–00932. The full funding state-
ment should read:
The study was partly funded by the Irish Centre for Fetal and Neonatal Translational
Research (INFANT) (grant no. 12/RC/2272), Strategic Research Programme in Diabetes at
Karolinska Institutet (Swedish Research Council grant No 2009–1068), the Stockholm County
Council (ALF), and the Swedish Kidney Foundation. Additional funding to KK from the
Swedish Research Council grant no. 2018–00932. No funding bodies had any role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
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